33:12

Individualized Treatment for Generalized Myasthenia Gravis

46:41

Defining and Delivering Person-Centric HIV Care in Key Populations

01:02:40

Adopting Modern Management Strategies for Obesity

01:02:55

Overcoming Challenges in the Management of Severe Asthma: Emerging Strategies for Optimal Care

01:00:37

Brain Health Essentials: Adapting Clinical Practice and Workflows to Optimize Cognitive Functioning

01:00:59

EGPA: Updated Strategies for Diagnosis, Treatment, and Reducing Steroid Burden

26:16

Referring Pediatric Patients With Eosinophilic Esophagitis to Specialty Care for Timely Treatment

47:12

Improving the Patient Experience in Geographic Atrophy

01:59

The Role of Type 2 Inflammation in EoE

52:37

BTK Inhibition as an MS Treatment Strategy

51:55

Dialing Up the Power of Alzheimer’s Disease Biomarkers for Earlier Diagnosis

01:04:44

Integrating Biomarker Testing Into Alzheimer’s Disease Workflows for Specialty Care

02:01

Neuroinflammation in Alzheimer’s Disease

01:05:15

Breaking Through Biases in Obesity Management

28:48

The Role of Neuroinflammation in the Pathophysiology & Management of Alzheimer’s Disease

32:49

Insights on Targeted Biologic Therapy in Patients With COPD and Evidence of Type 2 Inflammation

45:57

Innovative Approaches to Manage Primary Biliary Cholangitis

38:20

Navigating MOGAD

29:28

Individualizing the PBC Care Pathway

41:32

Advancements in IgA Nephropathy

01:03:04

Retinal Disease in Emergency Medicine

01:03:17

Advancements in IgA Nephropathy

35:47

Diagnose Early, Communicate Clearly: Optimizing Alzheimer’s Outcomes in Primary Care

50:08

Improving Kidney Transplant Access and Equity With Innovative Immunosuppression Strategies

33:07

Individualizing Management Plans for Type 2 Diabetes Through Shared Decision-Making

55:39

Mastering the Art and Science of Biologic Therapy for CRSwNP

40:45

A Collaborative Approach to Identifying EoE in the ED Emergency Presentation, Timely Diagnosis

35:36

The Importance of Patient Participation in Weight and Glycaemic Management for People With T2D

54:27

The New Normal: Digital Technologies for People Living With Insulin-Treated Type 2 Diabetes

39:24

Elevating Alopecia Areata Management

44:05

Comprehensive Strategies for Early Diagnosis and Effective Treatment in PPD

58:46

The New Era of ATTs in Alzheimer's Disease: Key Evidence, Considerations, and Best Practices

59:27

A New Standard of Alzheimer's Care: The New Era of Amyloid-Targeting Therapies

01:01:53

Clinical Research and Real-World Experience With Cardiac Myosin Inhibition in HCM & Beyond

39:24

Elevating Alopecia Areata Management

59:21

Bridging Diagnostic and Treatment Gaps in Transthyretin Cardiac Amyloidosis

01:02:05

Pharmacy Takes on Navigating the Therapeutic Landscape for Endometrial & Cervical Cancers

01:08:11

Hepatitis B and C: Understanding and Integrating New Guidelines and Advances in Disease Management

30:58

New Frontiers in Alzheimer s Disease Emerging Mechanisms and Therapeutic Advances

28:21

Intensifying Treatment for Type 2 Diabetes According to Current Guidelines

49:12

Managing Pulmonary Arterial Hypertension in the Era of Novel and Emerging Treatment Options

01:00:47

Changing the Course of Alzheimer’s Disease: New Biomarkers to Improve Diagnostic Precision

01:21:25

In Pursuit of a Functional Cure for Hepatitis B

57:54

A New Approach in COPD: Biologic Therapy in Patients With Type 2 Inflammation

01:09:59

Exploring New Paradigms in Comprehensive Care for Cardio Renal Metabolic Diseases

28:20

Improving Care for Pediatric and Adult Patients With EoE: The Latest Evidence for Targeted Therapy

01:20:43

Optimizing Outcomes for Pediatric EoE: Timely Integration of Targeted Biologic Treatment

01:15:37

Alzheimer’s Disease Case Conference: Emerging Strategies for the Era of ATTs

55:53

Early Diagnosis and Evolving Management of Eosinophilic Esophagitis in the Era of Targeted Therapy

01:58

The Role of Type 2 Inflammation in COPD

02:19

Mechanism of Action for Covalent and Non-Covalent BTKi

20:53

COPD Treatment: The Potential of Targeted Biologics in Patients With Evidence of Type 2 Inflammation

01:04:53

Collaborative Sequential Approaches for R/R CLL

59:06

The Burden of RSV in Pediatric Populations

01:04:03

Steering Away From Steroids in Myasthenia Gravis Management

30:47

Prioritizing Weight Management as a Primary Goal in People With Type 2 Diabetes

01:00:52

APOE as a Key in Alzheimer’s Disease Risk Management

59:00

Changing the Future for Families With HoFH

56:10

Experts vs AI Challenge: Diagnosing and Managing Nontuberculous Mycobacterial Lung Disease

01:05:02

TTRansforming the TTReatment of Hereditary Transthyretin Cardiac Amyloidosis